|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Constipation | |||||
| Neoplasms | |||||
| 2 | More general conditions related to this trial | ||||
| Signs and Symptoms | |||||
| Signs and Symptoms, Digestive | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Vinca Alkaloids | |||||
| 4 | More general drug interventions related to this trial | ||||
| Antimitotic Agents | |||||
| Antineoplastic Agents | |||||
| Mitosis Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| Tubulin Modulators | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institutes of Health Clinical Center (CC) | |||||